PARAMETEREXTRAKTION ZUR BESTIMMUNG DER ANALYTKONZENTRATION

European patent · EP4175545 · In force

Register entry

Publication number
EP4175545
Application number
EP21763243
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 4, 2021
Published
May 10, 2023
Granted
Jun 24, 2026
Protection ends at the latest
Aug 3, 2041
Next annual fee due
Aug 31, 2026
IPC classes
A61B 5/145 (2006.01)
A61B 5/1495 (2006.01)
Priority
US 202063061135 P 04.08.2020
US 202063061152 P 04.08.2020
US 202063061157 P 04.08.2020
US 202063061167 P 04.08.2020
PCT application
PCT/EP2021/071743 04.08.2021
PCT publication
WO2022/029164 10.02.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 24, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.06.2026

Parties

Holder

Ascensia Diabetes Care Holdings AG

Peter-Merian Strasse 90, 4052 Basel

Inventor

WU, Huan-Ping

Granger, Indiana 46530, US

CERUTTI, Mark D.

Everett, Massachusetts 02149, US

HARRISON, Bern

Mocow, Idaho 83843, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.